Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases, Hereditary

Explore clinical trials studying Eye Diseases, Hereditary. Study availability and eligibility vary by location and protocol.

836 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases, Hereditary trial results

Completed

A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa

NCT00447993

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • University of Califoria, Davis Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Retina Group of Florida Hollywood, Florida, United States
View Trial Details
Completed

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

NCT04604899

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Gavin Herbert Eye Inst, Univ Cal Irvine Irvine, California, United States
  • Retina-Vitreous Associates Medical Group Los Angeles, California, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

NCT03298867

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • The Lennar Foundation Medical Coral Gables, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

NCT04964089

Conditions
Eye Diseases, Eye Diseases, Hereditary, Macular Degeneration, +10 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Northwest Arkansas Retina Associates Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 66 locations
View Trial Details
Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

NCT04583735

Conditions
Autoimmune Diseases, Behavior, Bronchial Diseases, +25 more
Locations
  • The Private Practice of Raymond Douglas Beverly Hills, California, United States
  • Perlman Medical Offices / UCSD La Jolla, California, United States
  • MACRO Trials Los Angeles, California, United States
  • Univ of Colorado Dept of Ophthalmology Aurora, Colorado, United States
View Trial Details
Completed

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

NCT03461211

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Kellogg Eye Center at University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT04592419

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +16 more
Locations
  • Northwest Arkansas Retina Associates Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
View all 141 locations
View Trial Details
Completed

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

NCT06389578

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Bascom Palmer Eye Institute - University of Miami Miami, Florida, United States
  • Barnes Jewish Hospital Washington University St Louis, Missouri, United States
  • Neuro-Eye Clinical Trials Bellaire, Texas, United States
View Trial Details

Related conditions